Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BP1002 |
Trade Name | |
Synonyms | BP-1002|BP 1002 |
Drug Descriptions |
BP1002 is a liposome containing an antisense oligonucleotide targeting BCL2 mRNA, which potentially decreases cancer cell viability (Cancer Res 2021;81(13_Suppl):Abstract nr 939). |
DrugClasses | BCL2 inhibitor 27 |
CAS Registry Number | NA |
NCIT ID | C170743 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BP1002 | BP1002 | 0 | 2 |
BP1002 + Decitabine | BP1002 Decitabine | 0 | 1 |